News

De Clercq & Partners proudly contributes in new Advanced Master in Biotech & MedTech Ventures

De Clercq & Partners proudly contributes in new Advanced Master in Biotech & MedTech Ventures

Share on social media

01 April 2022

A new Advanced Master in Biotech & MedTech Ventures was launched by the Solvay Brussels School of Economics and Management in collaboration with the ULB I3h Institute. The program addresses the thriving Belgian and European life sciences’ need for young entrepreneurial talent capable of taking on C-level management positions in early-stage Biotech and MedTech companies. De Clercq & Partners is honored and proud to contribute to this excellent new initiative which is designed to form the future managers in biotech and medtech.

Read more in the press release.

Follow us on Instagram